Zeke Capital Advisors, LLC Biogen Inc. Transaction History

Zeke Capital Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$187.54 - $223.02 $213,983 - $254,465	-1,141 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $221,091 - $278,563	1,141 New	1,141 $240,000
Q1 2020 Apr 24, 2020	SELL	$268.85 - $341.04 $281,754 - $357,409	-1,048 Closed	0 $0
Q4 2019 Jan 17, 2020	SELL	$220.06 - $304.07 $2,860 - $3,952	-13 Reduced 1.23%	1,048 $311,000
Q3 2019 Oct 18, 2019	SELL	$217.44 - $243.88 $749,298 - $840,410	-3,446 Reduced 76.46%	1,061 $247,000

Q2 2019 Jul 24, 2019	BUY	$219.29 - $241.72 $5,043 - $5,559	23 Added 0.51%	4,507 $1.05 Million
Q1 2019 Apr 29, 2019	SELL	$216.71 - $338.96 $45,509 - $71,181	-210 Reduced 4.47%	4,484 $1.06 Million
Q4 2018 Feb 11, 2019	SELL	$278.5 - $352.75 $992,017 - $1.26 Million	-3,562 Reduced 43.14%	4,694 $1.41 Million
Q2 2018 Jul 24, 2018	BUY	$257.52 - $306.91 $1.15 Million - $1.37 Million	4,461 Added 117.55%	8,256 $2.4 Million
Q1 2018 May 03, 2018	SELL	$260.13 - $367.91 $431,555 - $610,362	-1,659 Reduced 30.42%	3,795 $1.04 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $519,603 - $581,995	1,689 Added 44.86%	5,454 $1.74 Million
Q3 2017 Nov 09, 2017	BUY	$281.15 - $329.69 $1.06 Million - $1.24 Million	3,765	3,765 $1.18 Million

1,047

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $33B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Zeke Capital Advisors, LLC with notifications on news.